Global law firm Freshfields has advised HELM AG on the sale of its finished dosage form business, HELM Pharmaceuticals, to Noucor.
HELM Pharmaceuticals has been developing finished dosage form products for 30 years, giving customers access to a broad portfolio
Freshfields advises the underwriting banks on the £500m equity raise by Land Securities Group PLC
By Freshfields
Global law firm Freshfields advised UBS AG London Branch, Barclays Bank PLC and Deutsche Bank AG, London Branch, as joint global co-ordinators, on the placement of 83.3 million ordinary shares in Land Securities Group PLC (Landsec), raising approximately £500 million.…
Freshfields advises Dürr on promissory note loan placement
By Freshfields
Global law firm Freshfields advised Dürr AG on the successful placement of a promissory note loan totaling €200m. The proceeds from the issuance will be used for general corporate financing.
The Dürr Group is a leading global manufacturer of machinery…
Freshfields Represents Akamai on $11.6bn Multi-year Agreement with Anthropic
By Freshfields
Freshfields is representing Akamai Technologies, Inc. (NASDAQ: AKAM) on transactions that will result in a significantly expanded relationship with Anthropic. These transactions provide for $11.6 billion of contractual commitment over seven years. The multi-year commitment will support Anthropic’s accelerating CPU…
Freshfields advises Federal Ministry on merger of Aleph Alpha and Cohere
By Freshfields
Global law firm Freshfields advises the Federal Ministry for Digital Affairs and State Modernisation (BMDS) on the establishment of an sovereign, global AI champion comprising the Heidelberg-based company Aleph Alpha and the Canadian company Cohere. The parties have signed a…
Freshfields advises HELLA on €300m bond placement
By Freshfields
Global law firm Freshfields has advised MDAX-listed HELLA GmbH & Co. KGaA on selected capital markets and corporate law matters in connection with the placement of a bond with a volume of €300m.
The unsecured bond has a four-year term…
Freshfields advises Grünenthal on its acquisition of cancer treatment Stivarga from Bayer
By Freshfields
Global law firm Freshfields is advising Germany-based pharmaceutical company Grünenthal, a global leader in pain management and research, on its agreement with Bayer AG to acquire the cancer treatment Stivarga® (regorafenib) for up to €375m. The acquisition is subject to…
Freshfields advises DEUTZ again on cash capital increase via accelerated bookbuilding
By Freshfields
Global law firm Freshfields has advised DEUTZ AG, a company listed on the MDAX, on its cash capital increase via accelerated bookbuilding. Approximately 15.3 million new shares were issued to institutional investors at a placement price of €11.70 per share,…
Freshfields advises Ontario Teachers’ on sale of its interest in Westerleigh Group
By Freshfields
Global law firm Freshfields is advising Ontario Teachers’ Pension Plan Board (‘Ontario Teachers’) on its agreement to sell Westerleigh Group, a leading independent developer and operator of crematoria and cemeteries in the UK which is jointly owned by Ontario Teachers’…